Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Flavonoids and Anti-Viral activity.
This is as close as I could come to finding some scientific evidence of the usefulness of Flavonoids in fighting a Viral load.
The Viro Spectrum Shield is basically plant matter that consists of Flavonoids.
Flavonoids are natural biomolecules that are known to be effective antivirals. These biomolecules can act at different stages of viral infection, particularly at the molecular level to inhibit viral growth. Enterovirus A71 (EV-A71), a non-enveloped RNA virus, is one of the causative agents of hand, foot and mouth disease (HFMD), which is prevalent in Asia. Despite much effort, no clinically approved antiviral treatment is available for children suffering from HFMD. Flavonoids from plants serve as a vast reservoir of therapeutically active constituents that have been explored as potential antiviral candidates against RNA and DNA viruses.
Question for this board:
Will the stock price ever go to.015?
If so, isn’t that a 50% return?
Where will you find such a handsome return?
Now ask yourself this question: Why aren’t I buying shares at this price?
Nobody can buy cheap shares unless they are willing to pay higher prices. It is too late to accumulate below a penny. Now, if you try to buy, the Market will continue to move the ask higher and higher. The golden opportunity is lost at this level. But you can still accumulate under 2 pennies for a while. If you look back at many of my previous posts, you will see that I wrote this exact scenario. Today has been ZERO trades so far because nobody wants to buy at these higher prices. But when we hit 3 pennies, once again, you will regret not buying right now.
The BA-2 Covid Variant is becoming a dominant strain in the United States and Britain. Some Testimonials that VSS actually reduces the symptoms, or possibly cures an individual from the virus would be a BOON for GSPI. Interesting to see if we get any evidence of efficacy towards any viruses at all. Hope- Springs eternal.
Rebranding of Viro Spectrum Shield will be of interest to me since I have continued to ask for validation of efficacy. Not only have we never seen any data or proof of concept results, there has not been one Testimonial ever since the USA Today advertisement. One cannot prove, nor disprove, the effects of VSS without significant clinical trials and a pocket full of money. But Testimonials might be a different species. Testimonials might provide insight into whether some people achieve positive results. It might also reveal that some, who have contracted any number of viruses, have had no significant improvement besides the usual 7 to 10 day infection process. I look forward to seeing whether we receive any Testimonials and whether there has been any significant sales of VSS. My instinct tells me that we will not receiver EITHER of these. But time will tell.
2021 December Year End Quarterly report is due by March 30th. Unless it has some sales numbers or a signed contract for $1 Million orders, or more, the stock price will continue to flounder. The numbers need to be mentioned. Promises or Forward looking statements are not good enough.
Now that the Stock Transfer company has disseminated all of the SEC Form 14C, is there a requirement for X number of days to allow existing investors to understand about the Merger or does the delay exist within the SEC to validate that there are no lawsuits or undocumented debts, etc? Why does this process take so long?
Centiment IO is a new technology utilizing AI to figure out how you "FEEL" and when to advertise to the greatest benefit. This is as much as I have gathered. I'm not impressed with this idea. Either people want the product or they don't. AI is not going to alter their decision making abilities. Most decisions are emotionally biased and monetarily determined.
Centiment Adtech uses artificial intelligence to find out how your audience FEEL and the BEST time to serve an ad.
This puppy is only trained to lie down. We need to teach him to get up off his Butt and run and fetch a big stick.
Today’s Press Release was a small stepping stone towards sales. Nobody wants to jump in and buy on this news. Maybe once there is more readership later today or tomorrow. Most likely, everyone is waiting for the Year End Quarterly report. I hope this report contains some numbers. If not, we wait another 3 months until there is a sales contract. I was able to fill the last of my buy order from yesterday so the drop in share price did help me.
I liked the TVT Lubricant Line as well.
I have held stock since that time.
Today is different, however. Kristy is actually getting the projects out of the lab and into the streets.
I still hold little hope for VSS, but Montana Biotics will be huge.
Joe owns 1/3 of the Patent for Graphene. Maybe by now, he has bought out the other partners. But there is a chance they can weave some Graphene into the Marketplace.
The Year End Quarterly report is due out within one week.
This should be informative on where the company stands and where it is going.
Not sure exactly what a "Big Check" might mean, but hopefully you will see a profit for your patience.
Just one contract and we gap up
to 2 pennies.
I added to my position again today.
I was lucky to get over 100K at .0095.
But I could not get anymore shares after that one trade, even though my bid was higher.
Everyone is holding and waiting.
All it takes is ONE CONTRACT.
We don't want to hear about Rebranding. We want a contract.
Lets see what happens when the Year End Report is published.
Considering the explosive establishment of 10 Billion Shares, one would think they intend to uplist to NASDAQ in the future.
What is required to uplist to Nasdaq?
First, the company that wants to get uplisted must have a total of $11 million in pre-tax earnings in the last three years. And in the past two years, a minimum of $2.2 million. Furthermore, a company cannot be in a net loss in the last three years to get uplisted. These three standards must be met to get uplisted.
Anybody care to call Yung Yeung? (aka: Yang Rong, Benjamin Yeung)
Yung Yeung Phone Number
(626) 353-8061 Cellphone by New Cingular Wireless Pcs, LLC, one person associated
Good research. He holds about 7% of Golden Ally Lifetech Group.
Others hold much more stock.
You can be sure that he will be able to facilitate an increase in sales and revenues by his connections. He will most likely not be selling any shares, but rather, he will be buying more shares. Accumulating shares is actually betting on yourself. He knows what he is worth and what he brings to the table. We are holding the tiger by the tail. Hang on for the ride!
Maybe, but meanwhile, Golden Ally is striving for new business, new contracts, new Patents, prototypes for products, Research and Development and architectural designs for the new Auto Manufacturing plant.
They have revenues and they have ongoing businesses, including new business ventures. They are not sitting idle. They are working diligently and smartly................for us, while we are waiting.
A new stock symbol with a corporate business plan and greater exposure will move the stock price immediately. Signet had nothing going for it and the price reflected this. Now we have a management team with Directors that know what they are doing. They have Patents, they have ongoing businesses and they have revenues. This will jump with the new stock symbol.
I have 2 questions:
1- What do the "High Level Investors from Golden Ally" receive in terms of the new Stock symbol? Signet shareholders are only part of the equation. Golden Ally shareholders will also be getting shares of the new corporation. If it has been agreed that the conversion is 1:1, then the people from Golden Ally will own 50% of all of the new shares and Signet shareholders will own 50% of all of the new shares. How will this be accomplished?
2- If they subsequently add 10 BILLION shares to the float, will this dilute the original shareholders?
On March 1, 2022, our Board of Directors took action by written consent approving our proposed Amended Charter and recommend our stockholders to approve and adopt the same. On March1, 2022, the Majority Stockholders took action by written consent approving and adopting the Amended Charter. The Amended Charter, among other things:
- increases the number of authorized shares of our Common Stock from One Hundred Million (100,000,000) shares, par value $0.001 per share, to Ten Billion (10,000,000,000) shares, par value $0.00001 per share;
So the question is: Will all shareholders immediately receive an increase in their shares relative to the new number of shares? For Example: if 100 Million shares are outstanding and the new number of shares will be 10 Billion - Will all Signet shareholders immediately own 100 Times more shares? Or maybe only 50 Times more shares so that the new entity can work with the extra 5 Billion?
There will have to be some shuffling of the number of shares to make all of this work and be equitable. The new entity will want to have the luxury of selling extra shares to Institutions and to manufacturers as incentives to build out the manufacturing plants, order parts, hire technical staff, etc. How will all of this shake out?
I found the answer:
"4,473,720 issued and outstanding shares of the Company’s issued and outstanding Common Stock,representing approximately 77.2% of the voting power of our issued and outstanding capital stock."
4.473/.772 = 5.79 Million.
Where did you get the 5.5 Million float?
Signet has 20.54 Million shares.
The 14C form only reveals the top Insiders.
There are many more shareholders that were not mentioned.
If Signet has 5.5 Million shares amongst it's shareholders and Golden Ally has 7 High Level Directors, how many TOTAL shares will the new entity hold? And won't they also own 50% of total shares if there is a 1:1 conversion?
This implies that either there will be 11 Million total shares, or they will maintain 5.5 Million but Signet shareholders will have to cut their shares by 50%.
I added 130,000 shares today.
I had to pay .0101.
The only way to buy shares these days, is to pay the ask. So I did. You might pick up 100 shares below.01, but to accumulate requires paying the going rate.
Glad to hear it. Anybody who sells out before $20 per share is crazy.
Watch what happens before the end of 2023. We need a few Quarterly reports before we can take any Quantum leaps in the stock price. There will probably be ZERO selling. So anybody who wants in, will have to pay the price.
I thought I might include a quote that was once told to me.
The Quote is: "Opportunity comes to those who are prepared to receive it."
In the context of GSPI, the opportunity is to buy and hold stock in this company for a lifetime.
Use it as your bank account. Whenever you need money, or just want money, you sell a small number of shares.
But first you had to have been prepared to buy shares and it is best to have been buying while the stock price was well below a penny.
You could have been buying along with me at .0052, .006, .007, .008, .009 and even more recently at .01.
But you needed to prerequisites: 1- You needed to have the money available and 2- You needed to have the vision when the opportunity was available.
It is still not too late.
I think .01 is going to look like you broke into Fort Knox when the stock price gets to $1.00.
Why do I believe this is possible?
Once the Agricultural Industry learns that they can avoid all pests that damage their crops, they will be buying the Montana Biotics in Container loads. And every season, with every crop planted, the irrigation system will be filled with the Montana Biotics. It is not a reusable chemical. It requires continuous purchases.
And that is only one of the products that will be a huge revenue stream.
The TVT Green Lubricants will result in the same high level of distribution.
I can't predict the direction of any other products, but I can predict that Kristy will not only continue on as the CEO, but she will be able to negotiate much better bonuses and salary for the work she is doing.
She is finally taking advantage of all the products ad research that went into forming this fledgling company for 30 years.
This is the moment of truth. The pivotal moment when this company turns the chapter from being negative to immensely positive.
If you only want 10,000 shares, you can probably get that order filled. If you want to accumulate a significant position you will have to pay much higher prices now. The time to accumulate a large position at great prices has passed you by.
Xiaodong Yan has connections to China. Many products could be Fast Tracked into China from Yan's contacts. All investors in China will probably begin to accumulate shares once the new stock symbol is released. This company is going to be huge (as will the revenues).
And don't forget that the Insiders own 95% of the company. It doesn't get any better than this. Talk about confidence going forwards. Institutions will have to pry shares from their tight fisted grip.
Dr. Yunfeng Lu is expected to continue to serve as a Director and the Chairman following the Change of Control. Dr. Lu specializes in materials, catalysis and electrochemistry in physical chemistry. Dr. Lu is an outstanding scientist in the fields of graphene production technology, nano material manufacturing technology and application, and advanced power battery, with more than twenty patents. Dr. Lu is also a project reviewer for the U.S. National Foundation, winner of the Presidential Early Career Award for Scientists and Engineers in 2005. Dr. Lu was appointed as a tenured professor at Tulane University in 2005, tenured professor at University of California, Los Angeles in 2007. He is also one of the first winners for China Thousand Talents and Cheung Kong Scholars.
Dr. Oliver Keren Ban is expected to continue to be a Director and serve as Chief Executive Officer following the Change of Control. Dr. Ban is an international Project management expert. He has over three decades of international operation experience in many Europe, Asian and American countries, proven tracking record in cross continents managing experience, extensive biotechnology, telecommunication and semiconductor industrial experience from application to manufacturing. He has outstanding analytic/quantitative problem-solving skills; he is also process efficiency expert with Certified Master Black Belt in Lean Six Sigma. Along the way, he has taken positions like Manager, Director, Chief Technologist, Senior Vice President and Chief Executive Officer positions in many different companies ranging from Integrated Information Technology, Sony Research Laboratories, Synopsys Inc. and International Business Machines Corporation. Dr. Ban has several issued and pending patents, his education background include a Ph.D in Computer Science; a Master of Business Administration from ??University of Texas at Austin.
Dr. Wen Li is expected to continue to be a Director and serve as Chief Technology Officer following the Change of Control. Dr. Li has extensive program and project development experience, management skill and abilities to work in world-class companies including Toyota, General Motors, Boeing and a major automotive battery manufacture in People’s Republic of China (“China”). Dr. Li demonstrated leaderships and abilities of initiative such as successfully establishing Toyota’s advanced material R&D activities in North America and new businesses in fuel cell and lithium-ion battery recycling for the major automotive battery company in China. He also demonstrated scientific/technical ability and problem-solving skills with sixty-seven issued patents and twenty-six published papers and ability to lead international business development with the skills of technical judgment, contract negotiation, Export Administration Regulations and International Traffic in Arms Regulations clarification, and patent application. Dr. Li has extensive laboratory experience and technical knowledge related to batteries, fuel cell, hydrogen storage and catalytic materials. Dr. Li received his B.S. and M.S. degrees in Chemical Engineering from Tianjin University and Ph.D. in environmental chemistry and engineering from Tokyo Institute of Technology.
Mr. Carter Yeung is expected to continue to be a Director and serve as Chief Marketing Officer following the Change of Control. Mr. Yeung served as Chief Executive Officer of HK Unlimited Solutions, focus on engineering problem solving for Hybrid Kinetic Group, and strategic partner seeking. Mr. Yeung received his B.A. degree in political science from Johns Hopkins University.
Mr. Jimmy Wang is expected to continue to be a Director and serve as Chief Accounting Controller and Treasurer following the Change of Control. Mr. Wang has more than twenty years of experience in non-profit organizations and listed companies. He has extensive experience in financial management, financial audit, internal audit, regulatory compliance management. Mr. Wang was majored economics and accounting information.
Mr. Tak Yiu Cheng is expected to continue to serve as Chief Financial Officer following the Change of Control. Mr. Cheng is a greater China investment expert with more than twenty years’ experience. Mr. Cheng was former investment analyst at T. Rowe Price Group focused on Greater China. He also served as a research analyst at several global investment banks, including Credit Suisse, BNP Paribas, and Deutsche Bank. Mr. Cheng received his BEng from the University of Hong Kong. He is a holder of CPA and CFA certifications.
Mr. Xiaodong Yan is expected to continue to serve as Chief United Nations Officer following the Change of Control. Mr. Yan received his B.A. degree from the Shanghai Institute of Foreign Trade and MBA degree from Peking University. From 1997 to 2007, he worked for the Ministry of Commerce of China, participated in negotiations for China’s accession to the World Trade Organization and bilateral trade and investment relations with the European Union. Then he was responsible for coordination of Chinese overseas investment projects (above $100 million), especially in power and telecommunication sectors. From 2009 to 2010, Mr. Yan worked for the China General Nuclear Power Group. He completed the first overseas acquisition of a uranium mine in Australia, and then others in the U.S. and Africa. He moved to New York City in 2010 from Beijing. Since then, he has been active in promoting bilateral investment between China and the United States, mostly in renewable energy vehicle industry and others.
Mr. Vincent Wang is expected to continue to serve as Secretary following the Change of Control. Mr. Wang serves as the Board Secretary of Golden Ally. Mr. Wang was previously the Secretary and a Director of Nevada Gold Holdings, Inc. Mr. Wang was Vice President of Hybrid Kinetic Motors Corp. and also served as a director of American Compass, Inc., a wholly-owned subsidiary of the Hybrid Kinetic Group Limited. Mr. Wang has extensive experience in corporate governance as well as educational and linguistic fields. He holds a master’s degree in linguistics from the National Taiwan Normal University.
Amazing group of talent behind this company.
OK, so only the Market in general (you and I and anyone else who cares) will begin to trade the new stock symbol. This requires transparency about what the new company has to offer. Revenues need to be robust enough to move the stock higher. This muddies the waters just a bit until valuations can justify a higher stock price. This will take some time unless existing revenues will support a large jump in price. Time will tell. I still would not attempt to trade this for at least another year. The more eyes on the stock, the higher it will go. Thanks for your help.
Although you might place a sell order at $1.50, the new stock symbol will trade long before the SIGN stock price will move this high.
I think you should just wait for the new stock symbol.
If you are holding Restricted shares, then you cannot sell for another 12 months.
If you bought in the Open Market, then you can sell at any time.
But you don't know what price the Underwriter will assign to the new stock. It will most likely be based on what the company can produce within the next calendar year. So it could begin to trade at $2, $3, or $4.
Patients is a virtue.
It is also possible that many elite investors in China might buy this stock once it is on the exchange because they know what Yeung can do. They might not have been able to buy into a private company, but now they have access to investing in a public company with Yeung. He still has an up & running company out of Hong Kong. His name still carries a lot of weight and confidence. Don't underestimate what he can do. Each patent has enormous value.
I think this is a mistake. Don't sell anything. You already know you will have plenty of time to sell. Let the Exchange decide the Opening Price and then leave it, unless you need the money. Just enjoy the ride. Believe me, the Private investors want the stock to go higher just like everyone else. There are too many amazing aspects to this company. I think Yeung wants to go Public to bring in more operating capital rather than to give existing holders the change to bail out. An influx of cash allows for additional purchases and flexibility to grow. I suggest you rethink your strategy. Risk reward ratio: Do you really need the money? Do you really want a small payment, or would you enjoy watching it grow exponentially over the next 3 or 4 years? After 3 years, maybe you could peel off some cash and go on a 3 Month cruise. Hang in there with me.
You will have one year to get a handle on the immensity of their undertakings. Yeung was forced to leave China due to charges of embezzlement. He was the richest man in China in 2001. He cannot allow such a reputation, so he is determined to do this again and he will bring with him all that he has learned. He MUST save face. This is a personal mission. He wants his name back and his reputation. So he will hold shares just like Bill Gates and Steve Jobs. His team also knows what he can do, so they believe in him as well. His mission is to do for the United States what he could have done for China. Along with his personal goals, his team has multiple patents and many irons in the fire. A total of 6 existing companies are behind his name. I believe that when he adds another 9 Billion to the float, those shares will be used to develop Manufacturing plants as well as buy more companies to add to his collection. I would never bet against a man like Yeung. He does not play with Fool's Gold. He is the real thing. His 10Q's will provide proof. The revenue will provide proof. The stock price will provide proof. I am guessing that within 3 years he will take his company onto NASDAQ. Then the visibility will forever change the scope of this company. The stock will also probably split once it hits $40. Try to imagine what our shares will look like.
Glad to hear that you are willing to hold. I can see the stock price going way beyond $20. Within 10 years approaching $100. Their Graphene could dominate the Automobile industry for auto frames as well as our future batteries. There are many more cookie in the cookie jar that haven’t been fully developed. Those from the Private side might take off a few shares for vacations and sports cars, but not to get out for a quick profit. They know they are in the infancy stage of a much larger entity. Also. Dr Yeung feels the need to prove himself and regain his name and self esteem. He will never sell.
Considering all 6 companies and patents, you will not consider holding long term? This could be a Baby Tesla forming along with Medical lotion epithelial applications. Imagine getting insulin without injections? Just rub it in.
They are bringing everything. We are only offering the shell.
Those from Private will be holding shares that reflect the value of what they are bringing. Initially, perhaps, nothing changes. But once they offer more shares we will be facing a significant change. However, the increase in share price will more than compensate for the addition of billions of shares.
You need to factor in that there are other holders from Golden.
We will not see a dilution, but we will see a change in the share structure (I believe).
The new share price will be exciting. But even better, is when revenues are reported and the share price goes much higher. We have a very accomplished and aggressive CEO taking control. He also has many contacts as well as many companies under his control that he has already brought to the table. This is a great investment.